Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erdheim-Chester Disease (ECD)”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)UnknownNCT05092815
What this trial is testing

The Efficacy and Safety of HLX208 in Adult Langerhans Cell Histiocytosis (LCH) and Erdheim-Chester Disease (ECD) With BRAF V600E Mutation

Who this might be right for
Langerhans Cell HistiocytosisErdheim-Chester DiseaseLCH+1 more
Shanghai Henlius Biotech 25
Not applicableStudy completedNCT01417520
What this trial is testing

Clinical and Pathophysiological Investigations Into Erdheim Chester Disease

Who this might be right for
MyelofibrosisGaucher DiseasePulmonary Fibrosis+2 more
National Human Genome Research Institute (NHGRI) 88
Not applicableLooking for participantsNCT02285582
What this trial is testing

International Rare Histiocytic Disorders Registry (IRHDR)

Who this might be right for
Rare Histiocytic Disorders (RHDs)Erdheim-Chester Disease (ECD)Rosai-Dorfman Disease (RDD)+7 more
The Hospital for Sick Children 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT02523040
What this trial is testing

Lenalidomide for Adult Histiocyte Disorders

Who this might be right for
Langerhans Cell Histiocytosis (LCH)Histiocytoses Erdheim-chester DiseaseHistiocytic Sarcoma (HS)
Dana-Farber Cancer Institute 12